Delcath Systems (DCTH) Change in Account Payables (2020 - 2021)
Delcath Systems' quarterly Change in Account Payables came in at -$548000.0 in Q4 2021, up 59.82% year-on-year from -$342877.1 in Q4 2020, and down 1342.11% quarter-over-quarter from -$38000.0 in Q3 2021.
Delcath Systems has reported Change in Account Payables for 2 years, with the latest figure at -$548000.0 in Q4 2021.
- For the quarter ending Q4 2021, Change in Account Payables rose 59.82% year-over-year to -$548000.0; the trailing twelve-month figure through Dec 2021 stood at -$2.6 million (changed N/A YoY), and the FY2021 full-year result was -$1.1 million, up 74.16% from the prior year.
- Change in Account Payables for Q4 2021 stood at -$548000.0, down from -$38000.0 in the prior quarter.
- The five-year high for Change in Account Payables was -$38000.0 in Q3 2021, with the low at -$1.4 million in Q4 2020.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | - |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | -198.00 Mn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | - |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 221.00 Mn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 56.90 Mn |
| 10 | Delcath Systems | 383.27 Mn | 293.95 Mn | 21.26 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2021 | -548,000.00 |
| Dec 31, 2021 | -548,000.00 |
| Sep 30, 2021 | -38,000.00 |
| Sep 30, 2021 | -38,000.00 |
| Dec 31, 2020 | -1.36 Mn |
| Dec 31, 2020 | -1.36 Mn |
| Sep 30, 2020 | -673,000.00 |
| Sep 30, 2020 | -673,000.00 |